News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Treatment of Follicular Lymphoma

Treatment of Follicular Lymphoma

Episodes

Specialty:

All

Year:

All

EP. 1: The Biology of Follicular Lymphoma

January 18th 2016

EP. 2: Follicular Lymphoma Risk Stratification

January 18th 2016

EP. 3: 'Watch and Wait' Versus Therapy Initiation in Follicular Lymphoma

January 18th 2016

EP. 4: First-Line Therapeutic Options in Follicular Lymphoma

January 18th 2016

EP. 5: Treating Relapsed/Refractory Follicular Lymphoma

January 18th 2016

EP. 6: Monoclonal Antibodies in Follicular Lymphoma

January 18th 2016

EP. 7: The Role of Ibrutinib in Follicular Lymphoma

January 18th 2016

EP. 8: Combining Targeted and Immunotherapeutic Agents in FL

January 18th 2016

EP. 9: Novel Treatment Approaches in Follicular Lymphoma

January 18th 2016

EP. 10: Future Strategies in the Treatment of Follicular Lymphoma

January 18th 2016

Trending on OncLive

FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC

FDA Accepts NDA for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer

Dr Patel on the Unmet Need in EGFR+ Transformed Small Cell Lung Cancer

Dr Galsky on Systemic Therapy Advances in Muscle-Invasive Bladder Cancer

Dr Cooper on Biomarker Selection for DLL3-Targeted Therapies in ES-SCLC